Newsbenzinga
Scinai Immunotherapeutics H1 Net Income $1.6M Vs Loss $4.1M Prior Year; Revenues $949K Up From $773K YoY; Continues To Pursue ~$5M In CDMO Revenues For 2026
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…